295 related articles for article (PubMed ID: 25434391)
1. The role of cancer stem cells in glioblastoma.
Sundar SJ; Hsieh JK; Manjila S; Lathia JD; Sloan A
Neurosurg Focus; 2014 Dec; 37(6):E6. PubMed ID: 25434391
[TBL] [Abstract][Full Text] [Related]
2. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
[TBL] [Abstract][Full Text] [Related]
3. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
[TBL] [Abstract][Full Text] [Related]
6. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
7. Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.
Turaga SM; Lathia JD
CNS Oncol; 2016 Oct; 5(4):251-9. PubMed ID: 27616054
[TBL] [Abstract][Full Text] [Related]
8. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
9. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
Triscott J; Rose Pambid M; Dunn SE
Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
[TBL] [Abstract][Full Text] [Related]
10. Decoding the cancer stem cell hypothesis in glioblastoma.
Hale JS; Sinyuk M; Rich JN; Lathia JD
CNS Oncol; 2013 Jul; 2(4):319-30. PubMed ID: 24379973
[TBL] [Abstract][Full Text] [Related]
11. The evolving landscape of glioblastoma stem cells.
Yan K; Yang K; Rich JN
Curr Opin Neurol; 2013 Dec; 26(6):701-7. PubMed ID: 24152818
[TBL] [Abstract][Full Text] [Related]
12. Recognizing and correcting failures in glioblastoma treatment.
Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ
Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304
[TBL] [Abstract][Full Text] [Related]
13. [Glioblastoma, an example of translational research?].
Kroonen J; Nguyen-Khac MT; Deprez M; Rogister B; Robe P
Rev Med Liege; 2008; 63(5-6):251-6. PubMed ID: 18669189
[TBL] [Abstract][Full Text] [Related]
14. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.
Tomuleasa C; Soritau O; Rus-Ciuca D; Ioani H; Susman S; Petrescu M; Timis T; Cernea D; Kacso G; Irimie A; Florian IS
J BUON; 2010; 15(3):583-91. PubMed ID: 20941832
[TBL] [Abstract][Full Text] [Related]
15. The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture.
Haley EM; Kim Y
Cancer Lett; 2014 Apr; 346(1):1-5. PubMed ID: 24333730
[TBL] [Abstract][Full Text] [Related]
16. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
17. Glioma stem cells: turpis omen in nomen? (The evil in the name?).
Binda E; Reynolds BA; Vescovi AL
J Intern Med; 2014 Jul; 276(1):25-40. PubMed ID: 24708237
[TBL] [Abstract][Full Text] [Related]
18. Multilayered Heterogeneity of Glioblastoma Stem Cells: Biological and Clinical Significance.
Brown DV; Stylli SS; Kaye AH; Mantamadiotis T
Adv Exp Med Biol; 2019; 1139():1-21. PubMed ID: 31134492
[TBL] [Abstract][Full Text] [Related]
19. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Culture of Glioblastoma Brain Tumor Stem Cells.
Chesnelong C; Restall I; Weiss S
Methods Mol Biol; 2019; 1869():11-21. PubMed ID: 30324510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
